Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial.

导出 OA

翻译打印收藏纠错

第一作者： Haixia,Fu

第一单位： Peking University People's Hospital, Peking University Institute of Haematology, No. 11 Xizhimen South Street, Beijing, 100044, China.;Collaborative Innovation Center of Haematology, Peking University, Beijing, China.;Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China.;National Clinical Research Center for Haematologic Disease, Beijing, China.

作者： Haixia,Fu ^[1] ; Xueyan,Sun ^[1] ; Ren,Lin ^[2] ; Yu,Wang ^[1] ; Li,Xuan ^[2] ; Han,Yao ^[3] ; Yuanyuan,Zhang ^[1] ; Xiaodong,Mo ^[1] ; Meng,Lv ^[1] ; Fengmei,Zheng ^[1] ; Jun,Kong ^[1] ; Fengrong,Wang ^[1] ; Chenhua,Yan ^[1] ; Tingting,Han ^[1] ; Huan,Chen ^[1] ; Yao,Chen ^[1] ; Feifei,Tang ^[1] ; Yuqian,Sun ^[1] ; Yuhong,Chen ^[1] ; Lanping,Xu ^[1] ; Kaiyan,Liu ^[1] ; Xi,Zhang ^[4] ; Qifa,Liu ^[5] ; Xiaojun,Huang ^[6] ; Xiaohui,Zhang ^[7]

作者单位： Peking University People's Hospital, Peking University Institute of Haematology, No. 11 Xizhimen South Street, Beijing, 100044, China.;Collaborative Innovation Center of Haematology, Peking University, Beijing, China.;Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China.;National Clinical Research Center for Haematologic Disease, Beijing, China. ^[1] Medical Center of Haematology, State Key Laboratory of Trauma, Burn and Combined Injury, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China. ^[2] Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. ^[3] Medical Center of Haematology, State Key Laboratory of Trauma, Burn and Combined Injury, Xinqiao Hospital, Army Medical University, Chongqing, 400037, China. zhangxxi@sina.com. ^[4] Department of Haematology, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. liuqifa628@163.com. ^[5] Peking University People's Hospital, Peking University Institute of Haematology, No. 11 Xizhimen South Street, Beijing, 100044, China. xjhrm@medmail.com.cn.;Collaborative Innovation Center of Haematology, Peking University, Beijing, China. xjhrm@medmail.com.cn.;Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China. xjhrm@medmail.com.cn.;National Clinical Research Center for Haematologic Disease, Beijing, China. xjhrm@medmail.com.cn. ^[6] Peking University People's Hospital, Peking University Institute of Haematology, No. 11 Xizhimen South Street, Beijing, 100044, China. zhangxh@bjmu.edu.cn.;Collaborative Innovation Center of Haematology, Peking University, Beijing, China. zhangxh@bjmu.edu.cn.;Beijing Key Laboratory of Haematopoietic Stem Cell Transplantation, Beijing, China. zhangxh@bjmu.edu.cn.;National Clinical Research Center for Haematologic Disease, Beijing, China. zhangxh@bjmu.edu.cn. ^[7]

关键词 Acute graft-versus-host disease Haemopoietic stem cell transplantation Haploidentical Mesenchymal stromal cells Second-line therapy Steroid-refractory